Loading…
Cardio Diagnostics Holdings, Inc. is projected to rise to $1.80 by 2027, a +3% move from its current price of $1.75. CDIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.67 | $1.75 | $1.84 | +0.03% |
| May 30 | $1.63 | $1.75 | $1.88 | +0.06% |
| May 31 | $1.61 | $1.75 | $1.91 | +0.10% |
| Jun 1 | $1.59 | $1.75 | $1.94 | +0.13% |
| Jun 2 | $1.57 | $1.75 | $1.96 | +0.16% |
| Jun 3 | $1.55 | $1.75 | $1.98 | +0.19% |
| Jun 4 | $1.54 | $1.75 | $2.00 | +0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.54 | $1.75 | $2.00 | +0.23% |
| Week 2 | $1.46 | $1.76 | $2.12 | +0.45% |
| Week 3 | $1.40 | $1.76 | $2.21 | +0.68% |
| Week 4 | $1.36 | $1.77 | $2.30 | +0.91% |
| Week 5 | $1.32 | $1.77 | $2.37 | +1.14% |
| Week 6 | $1.29 | $1.77 | $2.45 | +1.37% |
| Week 7 | $1.26 | $1.78 | $2.52 | +1.60% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease.
Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform.
Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings, Inc. (CDIO) operates in the healthcare sector, focusing on cardiovascular risk assessment through epigenetic and genetic tests.
The current price is $1.75, the market capitalization is $5.18M, and it ranks 5274 among listed assets.
The year-by-year forecast shows a rising path in average prices from 2026 through 2050, with increasingly bullish signals later in the period. For example, 2026 has an average of $1.75 with a min of $1.05 and a max of $2.46, progressing to 2050 with an average of $5.93, a min of $2.67 and a max of $13.64, delivering a maximum forecast ROI of 238.9%.
A major floor 40.0% below — a decisive break under it would weaken the trend.
The nearest floor, 21.7% below — buyers have tended to step in here.
The nearest ceiling, 14.9% above — a clean break opens room to run.
A major ceiling 274.3% above — clearing it would confirm fresh momentum.
Key CDIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CDIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.61 | Buy | $1.66 | Buy |
| MA 10 | $1.58 | Buy | $1.64 | Buy |
| MA 20 | $1.71 | Buy | $1.70 | Buy |
| MA 50 | $1.88 | Sell | $1.99 | Sell |
| MA 100 | $2.30 | Sell | $2.39 | Sell |
| MA 200 | $3.00 | Sell | $3.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.12 | Neutral |
| Stoch RSI (14) | 96.03 | Sell |
| CCI (20) | 20.10 | Neutral |
| Williams %R (14) | -20.83 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | -4.37 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 79.17 | Neutral |
| TRIX (15) | -1.02 | Sell |
| Awesome (5,34) | -0.17 | Sell |
| Ultimate (7,14,28) | 57.63 | Neutral |
| Momentum (10) | -0.07 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 1.73 | Buy |
| ADX (14) | 20.56 | Sell |
| ATR (14) | 0.08 | Info |
The near-term technical picture is balanced, with NEUTRAL sentiment and a neutral RSI14 of 50.
The 50-day moving average is $1.88 and the 200-day moving average is $3.00, indicating a mixed short-term bias between near-term support and resistance levels.
Key levels to watch are a support at $1.37 and a resistance at $2.01. The 30-day price range runs from $1.26 to $2.43, and annualized volatility stands at 90%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.05 | $1.75 | $2.46 | 0% | Neutral | |
| $1.31 | $1.80 | $2.66 | +3% | Neutral | |
| $1.47 | $2.13 | $3.33 | +21% | Bullish | |
| $1.80 | $2.73 | $4.48 | +56% | Bullish | |
| $1.60 | $2.52 | $4.30 | +44% | Bullish | |
| $1.34 | $2.20 | $3.86 | +25% | Bullish | |
| $1.29 | $2.21 | $4.00 | +26% | Bullish | |
| $1.27 | $2.24 | $4.16 | +28% | Bullish | |
| $1.55 | $2.84 | $5.40 | +62% | Bullish | |
| $1.68 | $3.19 | $6.20 | +82% | Bullish | |
| $1.62 | $3.61 | $7.67 | +106% | Bullish | |
| $2.67 | $5.93 | $13.64 | +239% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.05 | $1.75 | $2.09 | +0.00% |
| June 2026 | $1.55 | $1.86 | $2.30 | +6.03% |
| July 2026 | $1.48 | $1.80 | $2.28 | -2.87% |
| August 2026 | $1.48 | $1.82 | $2.34 | +0.81% |
| September 2026 | $1.58 | $1.96 | $2.57 | +7.93% |
| October 2026 | $1.57 | $1.97 | $2.61 | +0.24% |
| November 2026 | $1.45 | $1.83 | $2.46 | -6.82% |
| December 2026 | $1.42 | $1.81 | $2.46 | -0.97% |
Click any year to see its month-by-month CDIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cardio Diagnostics Holdings, Inc.'s 2026 outlook centres on $1.75, within a $1.05 to $2.46 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CDIO could reach as high as $2.66, with a base case around $1.80 and support toward $1.31 — roughly +3% from $1.75. A consolidation phase looks the most probable path here.
Expect CDIO to range from $1.47 to $3.33 through 2028. The $2.13 average target implies a +21% move from current prices. That is up +18% on the projected 2027 average. Momentum favours further upside here.
The CDIO price prediction for 2029 points to an average of $2.73 (low $1.80, high $4.48) — a potential gain of +56% on today's $1.75. Buyers look set to stay in control over this stretch.
In 2030, CDIO is projected to trade between $1.60 and $4.30, averaging $2.52 — a potential gain of +44% from today's $1.75. That is -8% versus the projected 2029 average. Momentum favours further upside here.
Cardio Diagnostics Holdings, Inc.'s 2031 outlook centres on $2.20, within a $1.34 to $3.86 range. That is -13% versus the projected 2030 average. That marks a +25% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CDIO could reach as high as $4.00, with a base case around $2.21 and support toward $1.29 — roughly +26% from $1.75. Momentum favours further upside here.
Expect CDIO to range from $1.27 to $4.16 through 2033. The $2.24 average target implies a +28% move from current prices. That is up +1% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The CDIO price prediction for 2034 points to an average of $2.84 (low $1.55, high $5.40) — a potential gain of +62% on today's $1.75. Momentum favours further upside here.
In 2035, CDIO is projected to trade between $1.68 and $6.20, averaging $3.19 — a potential gain of +82% from today's $1.75. That is up +12% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Cardio Diagnostics Holdings, Inc.'s 2040 outlook centres on $3.61, within a $1.62 to $7.67 range. That is up +13% on the projected 2035 average. That marks a +106% change versus current levels. Momentum favours further upside here.
By 2050, CDIO could reach as high as $13.64, with a base case around $5.93 and support toward $2.67 — roughly +239% from $1.75. Buyers look set to stay in control over this stretch.
Investing $1,000 in CDIO today (≈ 571.428571 CDIO) could be worth
$3,389.18
+$2,389.18 (+239%) by 2050 · US Dollar
Based on the average projected CDIO price of $5.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CDIOwould be worth at today's price.
$1,000 invested in CDIO on May 27, 2025 (≈ 235.294118 CDIO) would be worth
$411.76
-$588.24 (-58.8%) today · 0.41× · US Dollar
Based on a CDIO entry price of $4.25 vs. today's $1.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.42 | $1,232.39 | +23.2% |
| 1 month ago | $1.82 | $961.54 | -3.8% |
| 3 months ago | $5.22 | $335.25 | -66.5% |
| 6 months ago | $2.88 | $607.64 | -39.2% |
| 1 year ago | $4.25 | $411.76 | -58.8% |
| All time (4.4y) ago | $294.6 | $5.94 | -99.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CDIO forecast.
Our base-case forecast reaches $3.50 around 2040.
Implied market cap at $3.50: $10.36M
Across the multi-year forecast, the asset shows a bullish trajectory with rising averages and notable ROIs further out. The 2028 average is $2.13 with an ROI of 21.5%, and the 2029 average is $2.73 with an ROI of 56%. By 2030 the average is $2.52 with an ROI of 44.3%, and by 2034 the average is $2.84 with an ROI of 62.3%.
The 2040 forecast pins an average of $3.61 with an ROI of 106.1%, and the 2050 forecast shows an average of $5.93 with an ROI of 238.9%.
These are estimates, not guarantees, and are subject to uncertainty and market conditions.
Tap a question to reveal the answer.
2030 average price is $2.52 with a min of $1.60 and a max of $4.30; ROI is 44.3% and sentiment is BULLISH.
Forecasts show a bullish trend from 2028 onward, with 2040 average of $3.61 and 2050 average of $5.93 and ROIs up to 238.9%; however these are estimates and not guarantees.
2034 forecast min $1.55, avg $2.84, max $5.40; the max indicates a potential to reach $5.40.
Current price is $1.75 and market cap is $5.18M.
30-day range is from $1.26 to $2.43; annualized volatility is 90%.
Cardio Diagnostics Holdings, Inc. Community Discussion
0Share your Cardio Diagnostics Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.